The Scientist

» biotechnology and disease/medicine

Most Recent

image: Abbott Acquires Diagnostics Firm

Abbott Acquires Diagnostics Firm

By | February 2, 2016

In a deal worth $5.8 billion, Abbott Laboratories is buying medical test–maker Alere.

0 Comments

image: Contributors

Contributors

By | February 1, 2016

Meet some of the people featured in the February 2016 issue of The Scientist.

0 Comments

image: Marriages of Opportunity

Marriages of Opportunity

By | February 1, 2016

New ideas for antibody-drug conjugate design

0 Comments

image: The Mycobiome

The Mycobiome

By | February 1, 2016

The largely overlooked resident fungal community plays a critical role in human health and disease.

10 Comments

image: Schizophrenia and the Synapse

Schizophrenia and the Synapse

By | January 27, 2016

Genetic evidence suggests that overactive synaptic pruning drives development of schizophrenia.

5 Comments

image: Who Owns CRISPR, Cont’d

Who Owns CRISPR, Cont’d

By | January 14, 2016

The US Patent and Trademark Office declares a patent “interference” and will seek to determine who has rights to the gene-editing technology.

1 Comment

image: Thermo Fisher to Acquire Affymetrix

Thermo Fisher to Acquire Affymetrix

By | January 11, 2016

The boards of both companies have agreed to a $1.3 billion deal, which is subject to Affymetrix shareholder approval.

0 Comments

image: Disease-Linked Genes Questioned

Disease-Linked Genes Questioned

By | January 6, 2016

Many patients with genetic variations linked to cardiac disorders do not exhibit any symptoms, raising concerns about the validity of incidental findings of genetic tests.

0 Comments

image: TS Picks: CRISPR Patent Edition

TS Picks: CRISPR Patent Edition

By | January 5, 2016

A challenge to the first CRISPR patent just got teeth.

3 Comments

image: Updating the Polio Vaccine

Updating the Polio Vaccine

By | January 4, 2016

Researchers develop new attenuated viruses that could support the eradication effort.

1 Comment

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Sequencing Reveals Genomic Diversity of the Human Brain
  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech